Skip to main content

Table 3 Reduction of mean diastolic blood pressure values at 6 and 12 weeks for each dose of olmesartan and amlodipine FDC

From: Efficacy of olmesartan amlodipine in Colombian hypertensive patients (soat study)

Olmesartan and amlodipine doses Baseline (mean ± SD) 6 weeks (mean ± SD) Difference initial/6 weeks (mean ± SD) p 12 weeks (mean ± SD) Difference initial/12 weeks (mean ± SD) p
20/5 mg (N = 183 patients) 93.44 ± 10.20 84.76 ± 7.79 8.79 ± 12.85 <0.001 79.24 ± 7.89 14.19 ± 12.89 <0.001
40/5 mg (N = 198 patients) 96.91 ± 7.98 86.68 ± 8.72 10.03 ± 10.67 <0.001 80.66 ± 6.67 16.25 ± 10.87 <0.001
40/10 mg (N = 47 patients) 103.26 ± 7.77 83.59 ± 8.22 20.09 ± 12.44 <0.001 78.43 ± 6.07 24.83 ± 10.41 <0.001
  1. N = 428 patients